Group One Trading, L.P. Viking Therapeutics, Inc. Transaction History
Group One Trading, L.P.
- $3.01 Billion
- Q2 2024
A detailed history of Group One Trading, L.P. transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 201,294 shares of VKTX stock, worth $14.7 Million. This represents 0.35% of its overall portfolio holdings.
Number of Shares
201,294
Previous 74,245
171.12%
Holding current value
$14.7 Million
Previous $6.09 Million
75.26%
% of portfolio
0.35%
Previous 0.23%
Shares
26 transactions
Others Institutions Holding VKTX
# of Institutions
462Shares Held
65.9MCall Options Held
6.24MPut Options Held
2.97M-
Vanguard Group Inc Valley Forge, PA10.1MShares$736 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$439 Million0.01% of portfolio
-
State Street Corp Boston, MA5.12MShares$373 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.25MShares$164 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$135 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $5.59B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...